The Latest Special Situations Articles from Streetwise Reports


Real Estate REIT Shows Strengthening Fundamentals

Research Report
  ()
Growth of net operating income and of net asset value is expected from this investment vehicle in the near and longer term, noted an Echelon Capital Markets report.

The Fed Has Lots of Room To Move Rates Higher

Contributed Opinion
  ()
The Fed's mandate is 2% inflation and maximum employment. Expert Ron Struthers believes they have lots of room to soften the job market. Struthers also sees promise with three stocks. Gilat Satellite is growing sales, Callon Petroleum is undervalued, and Zonte Metals has a unique situation.

The 'Bear Killer' Does it Again

Contributed Opinion
  ()
Expert Michael Ballanger reviews recent updates in the stock market to tell you where he believes it is headed and why he thinks October was "The Bear Killer," with countless bear markets ending and bull markets possibly beginning today, November 1, 2022.

Is This the Vaunted Fed Pivot?

Contributed Opinion
  ()
Expert Clive Maund believes the Fed may pivot soon. Read to find out why he believes this is true and where he thinks the market is heading.

Lumber Stocks Are Over Valued and Poised for a Plunge

Contributed Opinion
  ()
Markets will remain in a bear market for some time, and it is best to look for short trades. Lumber stocks ran up in price with high lumber prices and a post-Covid-19 recovery in the economy. They are priced too high and not reflecting lower lumber prices and a softer housing market induced by a coming recession.

Wall Street Hemophilia

Contributed Opinion
  ()
Expert Michael Ballanger of GGM Advisory reviews the current stock market, the outlook for gold, and how he believes everyone should move forward.

Six Charts You Need To See Showing the Coming Bear Market

Contributed Opinion
  ()
Expert Michael Ballanger takes a look at a few charts to tell you how he believes the US dollar is doing and where he thinks the market may be heading.

Analyst Says Buy Before Biotech Co.'s Clinical Trials

Research Report
  ()
Argenx SE has "several upcoming catalysts," noted a Wedbush report.

Timing the US Market Crash: A Roadmap

Contributed Opinion
  ()
Expert Clive Maund reviews the charts for the broad stock market to tell you when he believes the U.S. market will crash.

Publishing Co. Rated an 'Interesting Speculative Play'

Contributed Opinion
  ()
After a relatively big buyer appeared a week ago and bought a lot of stock from Legible Inc., expert Clive Maund believes something may be on the horizon for the publishing company.

Equipment Co.'s First Six Months 'The Strongest in Recent History'

Contributed Opinion
  ()
Expert Chris Temple of The National Investor reviews the latest updates with Enterprise Group Inc., including the announcement of its second-quarter results.

Small Biomedical Device Co. Is Ready to Take a Big Step Into Success

Contributed Opinion
  ()
After weathering some major setbacks, PetVivo Holdings Inc. is stepping it up. With their new product for osteoarthritis and the team's perseverance, they may soon show themselves as a diamond in the rough.

Showing Results: 1 to 24 of 24

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe